Vaccines
Two New TB Vaccines Prove Safe but Fall Short of Broad Protection in Large India Trial
The Phase 3 PreVenTB study of more than 12,000 people found the vaccines helped only certain groups against certain forms of tuberculosis — underscoring how hard a better TB shot remains.